New Harvest recently announced they are running out of runway. Isha Datar, Executive Director of New Harvest said that she is no longer confident that New Harvest will raise their budgeted total for the year. She fears that they must move from a growth mindset to survival mode due to the economic slowdown, which is delaying anticipated gifts.

A voluntary recall and facility shutdown by Abbott Nutrition has created a supply disruption for certain types of infant formula. President Biden has announced a series of measures to address the resulting crisis for families around the country, including action by the FDA help make up the shortfall.

The U.S. Food and Drug Administration issued new test results in February 2022 that are part of CFSAN's work to better understand and reduce potential exposure to Perfluoroalkoxy alkanes (PFAS) from foods.

A new European Commission roadmap reveals future directions for chemical regulation in Europe including maintenance of a rolling list of chemicals considered for risk management measures and grouping of chemically similar substances.

The US bioeconomy (biotechnology-based economic activity) currently contributes 5.1 percent or more of US GDP and has tremendous growth potential. Realizing that potential requires, among other efforts, investment by the government to advance innovation infrastructure including regulatory frameworks that are open to new technologies and don’t obstruct them.